Day: November 15, 2023

IoT Medical Devices Market Size Worth USD 505.52 Billion in 2032 | Emergen Research

Written by Customer Service on . Posted in Mergers And Acquisitions.

The rapid proliferation of the latest technologies, such as Machine Learning and Artificial Intelligence, is expected to drive the IoT Medical Devices Market demand Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global IoT Medical Devices Market is forecasted to be worth USD 505.52 Billion by 2032, according to a current analysis by Emergen Research. Rising investment in artificial intelligence for the implementation of digital medical devices, the emergence of connected cars, and the adoption of wearable technology are contributing to the growth of the market. The utilization of connected technology in the healthcare industry for the management of operational workflows and clinical tasks is encouraging the demand for the market. IoT has helped in connecting medical devices and offers better medical help to people. It has also...

Continue reading

Medical Devices Testing Services Market Size Worth USD 22.43 Billion in 2032 | Emergen Research

Written by Customer Service on . Posted in Mergers And Acquisitions.

The growing government initiatives on improving the healthcare infrastructure and improvement in medical device technology are driving the demand of the Medical Devices Testing Services Market Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global Medical Devices Testing Services Market will be worth USD 22.43 Billion by 2032, according to a current analysis by Emergen Research. The growth of this market can be attributed to the growing government initiatives on improving the healthcare infrastructure. The increasing healthcare budgetary allocation in the emerging economies is expected to drive the demand for the medical devices testing services market. The improvement in medical device technology has resulted in the increased efficiency of the devices and improved patient care, which in turn has increased the adoption of the testing...

Continue reading

In Silico Drug Discovery Market Size Worth USD 11.68 Billion in 2032 | Emergen Research

Written by Customer Service on . Posted in Mergers And Acquisitions.

The growing need for partnerships and collaboration among market players and the increasing need for cost-effective solutions will drive the In Silico Drug Discovery Market Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global In Silico Drug Discovery Market is forecasted to be worth USD 11.68 Billion by 2032, according to a current analysis by Emergen Research. The technology is useful in finding new molecules from the molecule library, identify drug targets, and develop personalized medicines in the industry. The application of computers makes the whole process quick and cost-effective. Several factors are aiding in the growth of the market, such as an increase in the number of people suffering, the flourishing healthcare industry, along with manufacturers’ approach towards reducing the overall cost associated with drug...

Continue reading

Cannabidiol Market Size Worth USD 46.47 Billion in 2032 | Emergen Research

Written by Customer Service on . Posted in Mergers And Acquisitions.

Increasing preference toward cannabis extracts, such as oils and tinctures, rising adoption of CBD-based products for treating various medical conditions and number of retailers selling Cannabidiol (CBD)-based products, and changing regulatory landscape for approval of CBD products across regions are key factors driving Cannabidiol (CBD) market revenue growth Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global Cannabidiol (CBD) market size was USD 3.86 Billion in 2022 and is expected to register a rapid revenue CAGR of 28.3% during the forecast period. Key factors propelling this growth include the rising preference for cannabis extracts, changing regulatory landscapes, and a surge in retailers offering CBD-based products. CBD, a natural compound in the cannabis plant, has gained significant traction for its potential health...

Continue reading

Indoor Farming Technology Market Size Worth USD 98.66 Billion in 2032 | Emergen Research

Written by Customer Service on . Posted in Mergers And Acquisitions.

Growth in the global population, coupled with the growing need for maximizing crop yield and limited availability of arable land, is driving the demand of the Indoor Farming Technology Market Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global Indoor Farming Technology Market will be worth USD 98.66 Billion by 2032, according to a current analysis by Emergen Research. The growth of this market can be attributed to the growing environmental concerns such as the depletion of soil quality and groundwater on applications of chemical-based solutions. Limited availability of arable land due to land degradation has resulted in the increasing adoption of the indoor farming system by the farm owners. Growing initiatives of the government regarding the adoption of indoor farming to meet the increasing demand for maximizing crop yield...

Continue reading

Psyence Group Announces SEC Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq Listed Newcourt Acquisition Corp

Written by Customer Service on . Posted in Mergers And Acquisitions.

TORONTO, Nov. 15, 2023 (GLOBE NEWSWIRE) — Psyence Group Inc. (CSE:PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing (“Psyence”), and Newcourt Acquisition Corp (Nasdaq: NCAC) (“Newcourt”), a special purpose acquisition company today announced that the registration statement on Form F-4 (the “Registration Statement”), filed by Psyence Biomedical Ltd. (“Pubco”) with the Securities and Exchange Commission (“SEC”) was declared effective by the SEC on November 13, 2023. The Registration Statement was filed in connection with the previously announced business combination between Psyence Biomed Corp (“Psyence Biomed”), a wholly owned subsidiary of Psyence, and Newcourt. Pursuant to the Amended and Restated Business Combination Agreement, prior to the...

Continue reading

Medical Radiation Detection, Monitoring and Safety Market Size Worth USD 1,709.45 Million in 2032 | Emergen Research

Written by Customer Service on . Posted in Mergers And Acquisitions.

The Medical Radiation Detection, Monitoring, and Safety market is driven due to the growing prevalence of cancer and the rise in the awareness of adverse effects on exposure to radiation. Vancouver, Nov. 15, 2023 (GLOBE NEWSWIRE) — The global Medical Radiation Detection, Monitoring, and Safety Market is forecasted to be worth USD 1,709.45 Million by 2032, according to a current analysis by Emergen Research. The medical radiation and safety equipment detection is applicable in nuclear medicine for the rapid identification of cancer. It has also helped in the monitor of fatal diseases through visual tracking. A rise in the prevalence of cancer and insurance coverage will also impact market demand. The rapid adoption among emerging nations such as China and India will also encourage the demand for medical radiation detection, monitoring,...

Continue reading

Tonner Drones and Yorkville Agree to Extend Convertible Bonds’ Maturity Date to June 5, 2024

Written by Customer Service on . Posted in Public Companies.

TONNER DRONES AND YORKVILLE AGREE TO EXTEND CONVERTIBLE BONDS’ MATURITY DATE TO JUNE 5, 2024 Cannes, November 15, 2023 at 6:00 pm Tonner Drones (FR001400H2X4 – ALTD) is pleased to announce that on November 15, 2023, it agreed with Yorkville Advisors (“Yorkville”), one of its main financial creditors, to amend the terms and conditions of the 23,000 bonds convertible into shares (“OCA”) issued on June 5, 2023. The terms and conditions of these OCAs initially provided for a maturity date of December 5, 2023, and that any OCAs that had not yet been converted into Tonner Drones shares by that date were to be redeemed in cash. On November 15, 2023, Tonner Drones and Yorkville agreed to extend this maturity date to June 5, 2024. In accordance with Tonner Drones’ press release dated June 7, 2023, OCAs that...

Continue reading

SOITEC REPORTS SECOND QUARTER REVENUE AND FIRST HALF RESULTS OF FISCAL YEAR 2024

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

SOITEC REPORTS SECOND QUARTER REVENUE ANDFIRST HALF RESULTS OF FISCAL YEAR 2024 Q2’24 revenue reached €245m, down 7% at constant exchange rates and perimeter compared to Q2’23 H1’24 revenue at €401m, down 15% both at constant exchange rates and perimeter and on a reported basis compared with H1’23 – in line with guidance H1’24 EBITDA1 margin2 stood at the robust level of 33% of revenue while the Company maintained significant investment in R&D Anticipated return to a slight year-on-year organic growth in H2’24, leading to a moderate downward revision of FY24 outlook: mid-single digit decline in FY’24 revenue expected at constant exchange rate and EBITDA1 margin2 anticipated around 35% Bernin (Grenoble), France, November 15th, 2023 – Soitec (Euronext Paris), a world leader in designing and manufacturing innovative semiconductor...

Continue reading

Eik fasteignafélag hf.: Interim results for the first nine months of 2023

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

The Interim Consolidated Financial Statements of Eik fasteignafélag hf. for the period 1 January to 30 September 2023 were approved by the Company’s Board of Directors and CEO on 15 November 2023 Key results of the Interim Consolidated Financial Statement are: Income from operations amounted to ISK 8,453 million Thereof, rental income amounted to ISK 7,115 million Adjusted EBITDA amounted to ISK 5,806 million One-time costs amounted to ISK 40 million. And EBITDA for the period amounted to ISK 5,766 million. Total profit amounted to ISK 6,886million. Net cash from operations amounted to ISK 3,498 million. The book value of investment properties amounted to ISK 130,677 million.  The book value of assets for own use amounted to ISK 6,003 million at the end of the period. Change in value of investment properties amounted to ISK 7,095...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.